Literature DB >> 33502740

Is lung resection appropriate for late octogenarians? Surgical outcomes of patients aged ≥ 80 years with lung cancer.

Y Iijima1, S Iwai2, A Yamagata2, N Motono2, K Usuda2, S Yamagishi3, K Koizumi3, H Uramoto2.   

Abstract

PURPOSE: This study aimed to determine the outcomes and prognostic factors associated with octogenarians who underwent pulmonary resection for lung cancer. METHODS/PATIENTS: From 2009 to 2018, 76 octogenarians underwent pulmonary surgery for lung cancer at the Kanazawa Medical University, Japan. They were divided into two groups (early and late octogenarians), and their clinicopathological characteristics and outcomes were investigated. Overall survival rates and recurrence-free survival rates were determined using Kaplan-Meier curves. Univariate and multivariate analyses were performed to identify prognostic factors.
RESULTS: Limited surgery was performed more often in the late octogenarian group; however, most perioperative factors were not significantly different between the two groups. The 3-year overall survival and recurrence-free survival rates were 61.2% and 52.8%, respectively. The median observation period was 37.5 (8.9-112.3) months postoperatively. Kaplan-Meier curves showed that age ≥ 85 years (late octogenarian), smoking history, and squamous cell carcinoma on histology were associated with worse survival rates. Multivariate analysis identified age ≥ 85 years (late octogenarian) (p = 0.011) and cigarette smoking (p = 0.025) as unfavorable prognostic factors for overall survival and recurrence-free survival, respectively.
CONCLUSIONS: Most octogenarians with an indication for surgery can tolerate pulmonary surgery. However, owing to the limitations of this retrospective, single-center study, future studies involving multiple-institutions are required to confirm our findings.

Entities:  

Keywords:  Lung cancer; Octogenarian; Outcome; Surgery

Year:  2021        PMID: 33502740     DOI: 10.1007/s12094-021-02554-4

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  3 in total

1.  Prognostic significance of systemic inflammation-based lymphocyte- monocyte ratio in patients with lung cancer: based on a large cohort study.

Authors:  Pingping Hu; Hongchang Shen; Guanghui Wang; Ping Zhang; Qi Liu; Jiajun Du
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

2.  Neutrophil-to-lymphocyte ratio evolution is an independent predictor of early progression of second-line nivolumab-treated patients with advanced non-small-cell lung cancers.

Authors:  Matthieu Dusselier; Elise Deluche; Nellie Delacourt; Julia Ballouhey; Thomas Egenod; Boris Melloni; Charlotte Vergnenègre; Rémi Veillon; Alain Vergnenègre
Journal:  PLoS One       Date:  2019-07-17       Impact factor: 3.240

3.  Platelet-to-lymphocyte ratio predicts the prognosis of patients with non-small cell lung cancer treated with surgery and postoperative adjuvant chemotherapy.

Authors:  Michihito Toda; Takuma Tsukioka; Nobuhiro Izumi; Hiroaki Komatsu; Satoshi Okada; Kantaro Hara; Hikaru Miyamoto; Ryuichi Ito; Toshihiko Shibata; Noritoshi Nishiyama
Journal:  Thorac Cancer       Date:  2017-11-03       Impact factor: 3.500

  3 in total
  2 in total

1.  Prognostic nomogram for predicting long-term survival in bronchopulmonary carcinoid tumor patients receiving resection.

Authors:  Qiao Li; Qichen Chen; Jinghua Chen; Zijing Wang; Pan Wang; Hong Zhao; Jun Zhao
Journal:  Ann Transl Med       Date:  2021-09

2.  Identifying octogenarians with non-small cell lung cancer who could benefit from surgery: A population-based predictive model.

Authors:  Ce Chao; Dongmei Di; Min Wang; Yang Liu; Bin Wang; Yongxiang Qian
Journal:  Front Surg       Date:  2022-07-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.